GRN and brain disorder: Moreover, altered miR-107 were associated with cytoskeletal pathology in a transgenic mouse model of AD and with granulin/progranulin expression regulation in vivo and in vitro, with implications for brain disorders (Wang et al., 2008a, 2010b).